Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ST FRANCIS HOSPITAL, INC.

NPI: 1467496802 · GREENVILLE, SC 29615 · General Acute Care Hospital · NPI assigned 06/16/2006

$13.03M
Total Medicaid Paid
395,641
Total Claims
323,752
Beneficiaries
191
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCCULLOCH, RAYMOND (CONTROLLER)
NPI Enumeration Date06/16/2006

Related Entities

Other providers sharing the same authorized official: MCCULLOCH, RAYMOND

ProviderCityStateTotal Paid
ST. FRANCIS HOSPITAL INC GREENVILLE SC $8.99M
ST FRANCIS HOSPITAL INC GREENVILLE SC $869K
ST FRANCIS HOSPITAL INC GREENVILLE SC $705K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 50,589 $1.60M
2019 52,186 $1.48M
2020 40,342 $1.17M
2021 63,804 $1.80M
2022 75,142 $2.61M
2023 62,961 $2.57M
2024 50,617 $1.82M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 28,836 24,887 $1.84M
80053 Comprehensive metabolic panel 19,474 16,348 $1.73M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,256 5,402 $832K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 8,270 7,179 $803K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 924 505 $453K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 5,714 4,434 $406K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,802 1,696 $373K
80048 Basic metabolic panel (calcium, ionized) 5,341 4,417 $336K
87086 Culture, bacterial; quantitative colony count, urine 3,527 3,135 $291K
81025 11,703 10,365 $290K
99284 Emergency department visit for the evaluation and management, high severity 20,829 18,110 $275K
36415 Collection of venous blood by venipuncture 5,009 3,504 $245K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 5,038 4,331 $236K
84702 3,167 2,611 $236K
87210 2,810 2,520 $234K
86900 2,305 2,056 $226K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 1,856 1,705 $192K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,177 1,055 $183K
96375 Therapeutic injection; each additional sequential IV push 5,952 4,898 $181K
81002 1,408 1,160 $178K
81001 7,472 6,666 $177K
77067 Screening mammography, bilateral, including computer-aided detection 2,910 2,748 $173K
82962 4,859 2,169 $156K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 5,757 2,618 $150K
71046 Radiologic examination, chest; 2 views 6,208 5,526 $142K
81003 8,282 7,302 $142K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,020 1,786 $139K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,482 1,283 $132K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 2,290 1,927 $116K
87081 1,210 1,104 $107K
0202U Oncology (prostate), multianalyte, gene expression profiling 953 830 $106K
77066 Tomosynthesis, mammo 870 825 $104K
70450 Computed tomography, head or brain; without contrast material 2,739 2,457 $98K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,895 1,594 $97K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 5,019 1,439 $94K
96361 Intravenous infusion, hydration; each additional hour 3,632 2,919 $92K
84112 250 201 $78K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 3,250 2,903 $65K
76642 2,308 1,830 $62K
72100 1,335 1,191 $60K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 8,063 7,148 $59K
73562 892 761 $57K
73630 852 683 $57K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 22,077 18,206 $50K
93971 387 329 $48K
71045 Radiologic examination, chest; single view 3,630 3,130 $48K
73610 422 362 $44K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,028 696 $44K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 452 382 $35K
73030 555 487 $35K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,595 2,345 $35K
77065 Tomosynthesis, mammo 736 638 $34K
74176 Computed tomography, abdomen and pelvis; without contrast material 900 796 $33K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 1,566 1,358 $33K
86850 927 820 $33K
85018 1,297 1,013 $32K
73130 326 270 $32K
87807 329 299 $32K
87186 623 542 $31K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 251 218 $29K
96376 1,207 777 $28K
87040 1,139 659 $26K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 304 265 $23K
85027 3,681 3,131 $19K
J7120 Ringers lactate infusion, up to 1000 cc 6,532 4,960 $18K
72040 234 196 $17K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 482 367 $15K
G0378 Hospital observation service, per hour 3,531 1,536 $14K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,259 1,151 $13K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 904 301 $11K
59025 Fetal non-stress test 3,745 2,739 $11K
74018 155 131 $11K
71260 Computed tomography, thorax, diagnostic; with contrast material 503 446 $9K
83036 Hemoglobin; glycosylated (A1C) 783 708 $9K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1,172 594 $9K
76830 Ultrasound, transvaginal 359 316 $8K
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,461 7,709 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,178 1,628 $8K
97161 939 788 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 7,426 6,470 $8K
73110 59 49 $7K
83735 4,182 3,482 $7K
84484 5,662 3,683 $7K
85379 1,112 1,006 $6K
82565 92 79 $6K
81015 644 556 $6K
J1170 Injection, hydromorphone, up to 4 mg 3,692 2,774 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 111 12 $4K
J2704 Injection, propofol, 10 mg 4,298 3,262 $4K
76705 Ultrasound, abdominal, real time with image documentation; limited 231 217 $4K
86140 848 751 $4K
99281 Emergency department visit for the evaluation and management, self-limited or minor 31 29 $3K
87634 191 181 $3K
85610 1,346 1,160 $3K
87641 282 270 $3K
82731 25 24 $3K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 13 13 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 3,208 2,863 $3K
80050 General health panel 32 26 $3K
A4216 Sterile water, saline and/or dextrose, diluent/flush, 10 ml 548 369 $3K
J2270 Injection, morphine sulfate, up to 10 mg 2,868 2,276 $2K
74022 210 180 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 182 108 $2K
94760 1,031 790 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 3,034 2,508 $2K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 73 55 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,414 6,207 $2K
72125 Computed tomography, cervical spine; without contrast material 198 183 $2K
J7030 Infusion, normal saline solution , 1000 cc 7,215 5,957 $2K
J0690 Injection, cefazolin sodium, 500 mg 2,031 1,313 $2K
87070 14 14 $1K
88307 212 184 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,055 3,649 $1K
73502 70 65 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 499 445 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,587 4,092 $1K
99215 Prolong outpt/office vis 49 40 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg 2,596 2,265 $996.28
J7050 Infusion, normal saline solution, 250 cc 1,865 1,397 $825.61
97162 53 50 $819.51
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 104 92 $775.78
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 13 13 $747.52
84443 Thyroid stimulating hormone (TSH) 203 187 $721.18
93975 138 128 $651.24
84550 149 127 $550.70
97597 23 15 $506.57
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 37 26 $482.40
82077 104 93 $479.97
87077 16 12 $453.41
A9575 Injection, gadoterate meglumine, 0.1 ml 198 179 $449.00
97165 196 184 $447.56
97535 Self-care/home management training, each 15 minutes 222 119 $414.64
J2550 Injection, promethazine hcl, up to 50 mg 1,333 1,097 $393.74
83605 2,251 1,831 $370.64
83690 7,612 6,568 $330.34
76801 248 233 $281.96
84132 28 24 $270.58
83880 493 411 $237.44
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 685 585 $214.55
94761 367 254 $154.00
94762 285 238 $129.18
84145 561 498 $104.88
77063 Screening digital breast tomosynthesis, bilateral 785 751 $58.54
85730 229 213 $56.48
80061 Lipid panel 123 112 $37.62
J3010 Injection, fentanyl citrate, 0.1 mg 3,027 2,726 $18.61
J3490 Unclassified drugs 2,287 1,627 $14.80
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,367 1,172 $5.12
86901 2,304 2,055 $3.80
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 178 160 $2.61
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 296 268 $2.01
J2765 Injection, metoclopramide hcl, up to 10 mg 731 634 $0.00
87088 281 259 $0.00
J2372 Injection, phenylephrine hydrochloride (biorphen), 20 micrograms 44 40 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 303 261 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 703 581 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 120 96 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 90 78 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 46 40 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 21 16 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 16 12 $0.00
85652 33 25 $0.00
J2060 Injection, lorazepam, 2 mg 96 85 $0.00
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 19 18 $0.00
88304 13 12 $0.00
86141 13 13 $0.00
84703 14 12 $0.00
83615 29 26 $0.00
87205 31 27 $0.00
94664 160 139 $0.00
A9576 Injection, gadoteridol, (prohance multipack), per ml 167 119 $0.00
J7510 Prednisolone oral, per 5 mg 13 12 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 760 685 $0.00
J3370 Injection, vancomycin hcl, 500 mg 36 25 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 381 329 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 58 50 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 88 72 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 61 40 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 45 41 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 38 38 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 161 151 $0.00
84156 15 13 $0.00
90715 14 12 $0.00
82570 44 37 $0.00
C1776 Joint device (implantable) 44 40 $0.00
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 56 55 $0.00
J1171 Injection, hydromorphone, 0.1 mg 17 13 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 44 27 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 19 18 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 37 15 $0.00
J0670 Injection, mepivacaine hydrochloride, per 10 ml 14 13 $0.00